These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35948739)

  • 1. HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report.
    Saed L; Balcerczak E; Łochowski M; Olechnowicz E; Sałagacka-Kubiak A
    Mol Genet Genomics; 2022 Nov; 297(6):1505-1514. PubMed ID: 35948739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.
    Zhang Z; Wang Q; Chen F; Liu J
    Tumour Biol; 2015 Feb; 36(2):1213-9. PubMed ID: 25344216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.
    Hillion J; Wood LJ; Mukherjee M; Bhattacharya R; Di Cello F; Kowalski J; Elbahloul O; Segal J; Poirier J; Rudin CM; Dhara S; Belton A; Joseph B; Zucker S; Resar LM
    Mol Cancer Res; 2009 Nov; 7(11):1803-12. PubMed ID: 19903768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.
    Zhang Y; Ma T; Yang S; Xia M; Xu J; An H; Yang Y; Li S
    Mol Cell Biochem; 2011 Nov; 357(1-2):363-71. PubMed ID: 21656127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of
    Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells.
    Sekimoto N; Suzuki A; Suzuki Y; Sugano S
    Mol Med Rep; 2017 Feb; 15(2):534-542. PubMed ID: 28000891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA1 Has Predictive Value in Response to Chemotherapy in Gastric Cancer.
    Pádua D; Pinto DF; Figueira P; Pereira CF; Almeida R; Mesquita P
    Curr Oncol; 2021 Dec; 29(1):56-67. PubMed ID: 35049679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between HMGA1 and immunosuppression in hepatocellular carcinoma: A comprehensive bioinformatics analysis.
    Zhu J; Zheng Y; Liu Y; Chen M; Liu Y; Li J
    Medicine (Baltimore); 2023 Jan; 102(4):e32707. PubMed ID: 36705364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of exosomal circPLK1 promotes the development of non-small cell lung cancer through the miR-1294/ high mobility group protein A1 axis.
    Li C; Wang G; Ma X; Tao T; Li Q; Yang Y; Sang H; Wang Z
    Bioengineered; 2022 Feb; 13(2):4185-4200. PubMed ID: 35114891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anoikis-related gene signature is associated with immune infiltration and predicts the prognosis of non-small cell lung cancer.
    Wu Y; Zhou Z; Qi Q; Xu S; Chen L; Wang F
    Aging (Albany NY); 2024 Feb; 16(3):2908-2933. PubMed ID: 38329444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.
    Hou P; Meng S; Li M; Lin T; Chu S; Li Z; Zheng J; Gu Y; Bai J
    J Exp Clin Cancer Res; 2021 Feb; 40(1):52. PubMed ID: 33526059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Rocha F; Matros E; Redston M; Whang E
    Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
    Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
    J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Value of Measuring PD-L1 mRNA Expression Levels in Surgically Resected Non-Small Cell Lung Cancer.
    Kim GJ; Lee JH; Park WJ; Lee HW; Hwang IS; Lee DH
    Ann Clin Lab Sci; 2019 May; 49(3):317-323. PubMed ID: 31308030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma.
    Toyozumi T; Hoshino I; Takahashi M; Usui A; Akutsu Y; Hanari N; Murakami K; Kano M; Akanuma N; Suitoh H; Matsumoto Y; Sekino N; Komatsu A; Matsubara H
    Ann Surg Oncol; 2017 Oct; 24(11):3446-3455. PubMed ID: 27882471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors.
    De Martino M; Pellecchia S; Esposito F; Tosti N; Quintavalle C; Eppenberger-Castori S; Carafa V; Righi A; Chieffi P; Fusco A; Terracciano LM; Pallante P
    Cell Cycle; 2022 Jun; 21(12):1335-1346. PubMed ID: 35282770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of doxorubicin with a regulatory element of hmga1 and its in vitro anti-cancer activity associated with decreased HMGA1 expression.
    Akhter MZ; Rajeswari MR
    J Photochem Photobiol B; 2014 Dec; 141():36-46. PubMed ID: 25313540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
    Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
    Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
    Wang CQ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3771-3778. PubMed ID: 31115003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer.
    Wang YT; Pan SH; Tsai CF; Kuo TC; Hsu YL; Yen HY; Choong WK; Wu HY; Liao YC; Hong TM; Sung TY; Yang PC; Chen YJ
    Sci Rep; 2017 Mar; 7():44021. PubMed ID: 28290473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.